Table 2 Serum sFas levels in ovarian cancer cases and controls from the three participating cohorts
From: Circulating soluble Fas levels and risk of ovarian cancer
Cohort | Serum sFas, ng/mL | ||
|---|---|---|---|
Cases | Controls | P -value* | |
NYUWHS | |||
n | 74 | 145 | 0.37 |
Mean (SD) | 6.8 (2.2) | 6.7 (2.1) | |
Median (10th–90th percentiles) | 6.5 (4.3 – 9.8) | 6.5 (4.2 – 9.5) | |
NSHDS | |||
n | 47 | 86 | 0.20 |
Mean (SD) | 8.1 (7.4) | 8.0 (2.2) | |
Median (10th–90th percentiles) | 6.6 (4.8 – 10.9) | 7.6 (5.5 – 11.2) | |
ORDET | |||
n | 17 | 32 | 0.07 |
Mean (SD) | 6.2 (1.3) | 6.7 (1.3) | |
Median (10th–90th percentiles) | 6.6 (3.9 – 7.6) | 6.4 (5.2 – 8.1) | |
Total | |||
n | 138 | 263 | 0.51 |
Mean (SD) | 7.2 (4.6) | 7.1 (2.2) | |
Median (10th–90th percentiles) | 6.5 (4.4 – 10.2) | 6.8 (4.5 – 10.1) | |